Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Kuan-Lin Kuo

1PUBLICATIONS

3CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Nov 13, 2021

PR-619, a General Inhibitor of Deubiquitylating Enzymes, Diminishes Cisplatin Resistance in Urothelial Carcinoma Cells through the Suppression of c-Myc: An In Vitro and In Vivo Study.

Fu-Shun Hsu, Wei-Chou Lin, Kuan-Lin Kuo

Pageof 1

Frequent Collaborators

1 joint publications

Fu-Shun Hsu

1 joint publications

Shing-Hwa Liu

1 joint publications

Kuo-How Huang

Frequent Collaborators

1 joint publications

Fu-Shun Hsu

1 joint publications

Shing-Hwa Liu

1 joint publications

Kuo-How Huang

Top Related Videos

Knockdown of <em>FAM83A</em> to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity

Knockdown of <em>FAM83A</em> to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity

Published on : Feb 09, 2024

See more related videos

Top Related Videos

Knockdown of <em>FAM83A</em> to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity

Knockdown of <em>FAM83A</em> to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity

Published on : Feb 09, 2024

See more related videos